Techniques of DNA methylation analysis with nutritional applications by Mansego-Talavera, M.L. (María Luisa) et al.
 © 2013 S. Karger AG, Basel
1661–6499/13/0062–0083$38.00/0 
 Review 
 J Nutrigenet Nutrigenomics 2013;6:83–96  
 Techniques of DNA Methylation 
Analysis with Nutritional Applications 
 Maria L. Mansego    Fermín I. Milagro    Javier Campión    J. Alfredo Martínez 
 CIBERobn, Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 
 Madrid , and Department of Nutrition, Food Science and Physiology, University of Navarra, 
 Pamplona , Spain 
 Key Words 
 DNA methylation · Nutrient · Epigenetic · Methylation-specific PCR · Pyrosequencing · 
MassARRAY · Microarray · Next-generation sequencing 
 Abstract 
 Epigenetic mechanisms are likely to play an important role in the regulation of metabolism 
and body weight through gene-nutrient interactions. This review focuses on methods for 
analyzing one of the most important epigenetic mechanisms, DNA methylation, from single 
nucleotide to global measurement depending on the study goal and scope. In addition, this 
study highlights the major principles and methods for DNA methylation analysis with empha-
sis on nutritional applications. Recent developments concerning epigenetic technologies are 
showing promising results of DNA methylation levels at a single-base resolution and provide 
the ability to differentiate between 5-methylcytosine and other nucleotide modifications such 
as 5-hydroxymethylcytosine. A large number of methods can be used for the analysis of DNA 
methylation such as pyrosequencing TM , primer extension or real-time PCR methods, and ge-
nome-wide DNA methylation profile from microarray or sequencing-based methods. Re-
searchers should conduct a preliminary analysis focused on the type of validation and infor-
mation provided by each technique in order to select the best method fitting for their 
nutritional research interests.  Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Nutrients promote changes in gene expression profile by affecting transcriptional and 
posttranscriptional mechanisms  [1] . They may also induce transient or permanent altera-
tions in the epigenetic marks that regulate the expression of genes involved in metabolic 
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processes and other biological networks, which could be one of the factors leading to the 
developmental origin of pathological conditions like obesity, insulin resistance, type 2 
diabetes, cancer, neurological and cardiovascular diseases, neurodegenerative diseases, and 
immune diseases  [2–7] .
 Epigenetics is defined as the heritable states of gene expression resulting from a set of 
reversible changes in chromatin structure without alterations in the DNA sequence  [8] . These 
changes may be induced in response to environmental or internal factors, and include different 
components of epigenetic control, such as nucleic acid modification, chromatin remodeling and 
histone modifications or noncoding RNAs ( fig. 1 ). Regarding nucleic acid modification, DNA 
methylation, mainly of cytosine nucleotide at the carbon 5 position (5-mC), is a common 
epigenetic mark involved in epigenetic regulation of gene expression in many eukaryotes and 
is often found in the sequence context CpG (cytosine followed by a guanine) or CpHpG (H: A, T, 
C)  [9] . Promoter methylation is typically associated with repression, whereas genic methyl-
ation correlates with transcriptional activity  [10] . Recently, the Encyclopedia of DNA elements 
(ENCODE) Project Consortium reported that levels of DNA methylation correlated with chro-
matin accessibility. They used reduced representation bisulfite sequencing (RRBS) to quanti-
tatively profile DNA methylation for an average of 1.2 million CpGs in each of 82 cell lines and 
tissues (8.6% of nonrepetitive genomic CpGs), including CpGs in intergenic regions, proximal 
promoters, and in intragenic regions (gene bodies)  [11] . They found that 96% of CpGs exhibited 
differential methylation in at least one cell type or tissue assayed. The most variably methylated 
CpGs are found more often in gene bodies and intergenic regions, rather than in promoters and 
upstream regulatory regions although the underlying mechanisms are unclear  [12] .
 In recent years, we are experiencing a revolution in the field of epigenetics. The devel-
opment of new technologies like next-generation sequencing (NGS) has allowed to detect 
deep (high coverage, where coverage is number of reads representing a given nucleotide in 
the sequence) and new epigenetic modifications such as 5-hydroxymethylcytosine (5-hmC), 
5-formylcytosine (5-fC) and 5-carboxycytosine (5-caC) in genomic DNA  [13] or N(6)-methyl-
adenosine (N6mA) in RNA  [14] . In addition, new sensitive methods have been developed to 
analyze different conditions and types of samples [biopsies, i.e. from muscle or adipose tissue, 
low amounts of input sample DNA, formalin-fixed paraffin-embedded samples (FFPE), whole 
peripheral blood, urine, saliva, plasma or serum]  [15] .
Epigenetic marks
Nucleic acid
modification
5-mC, 5-hmC, 5-fC, 
5-caC, 3-mC (DNA), N6mA 
(RNA), …
Noncoding RNAs
miRNA, piRNA, siRNA, 
lncRNA, lincRNAs, 
eRNA, PARs, …
Chromatin
remodeling and 
histone
modifications
Ubiquitination,
acetylation, biotinylation, 
ADP-ribosylation,
phosphorylation,
sumoylation, methylation
Environment
(diet, drugs-pharmaceuticals, stress,…)
Internal factors
(age, metabolic factors, development, 
disease…)
 Fig. 1. Schematic representation 
of the different components of 
epigenetic control and internal 
and environmental regulation. 
5-mC = 5-Methylcytosine; 5-
hmC = 5-hydroxymethylcytosine; 
5-fC = 5-formylcytosine; 5-caC = 
5-carboxylcytosine; 3-mC = 3-
methylcytosine; N6mA = N6-
me thyladenosine; miRNAs = 
micro RNAs; piRNAs = Piwi-inter-
acting RNAs; siRNAs = small in-
terfering RNAs; lncRNAs = long 
noncoding RNAs; lincRNAs = 
large intergenic noncoding RNAs; 
eRNAs = enhancer RNAs; PARs = 
promoter-associated RNAs. 
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 In this review, we discuss the technologies that can be suitable, in a nutrigenomic context, 
for the quantitative global analysis of DNA methylation or the methylation levels at specific 
loci in DNA. These techniques include pyrosequencing TM , primer extension or real-time PCR 
methods, and genome-wide DNA methylation profile from microarray or sequencing-based 
methods.
 Methods for Nucleotide Methylation Analysis 
 There are multiple methods to study nucleotide methylation. We report a series of tech-
niques that allow to quantify the 5-mC levels, mainly, and some other recent nucleotide modi-
fications such as 5-hmC.  Table 1 shows a scheme of the various techniques that can be used 
to quantify methylation according to the pretreatment that the DNA receives and the number 
of modified nucleotides and the resolution of the detection (global, specific-region or genome-
wide methylation). All of these approaches are based on one of three main pretreatment tech-
niques: sodium bisulfite conversion, enzyme restriction digestion or affinity enrichment. 
During bisulfite treatment, unmethylated cytosines in single-stranded DNA are deaminated 
to give uracil, while leaving methylated cytosine intact  [16] . Bisulfite conversion is the most 
conventional approach for pretreatment and is considered the gold standard for determining 
DNA methylation status because it offers single-CpG resolution  [17] . However, this treatment 
has some disadvantages such as typical calls for larger quantities of sample DNA, which can 
degrade following chemical treatment, it can be limited by incomplete conversion of all 
unmethylated cytosines to uracils, and bisulfite conversion cannot discriminate between 
methylcytosine and hydroxymethylcytosine. Moreover, enzyme restriction digestion 
treatment is based on the ability of some methylation-sensitive restriction endonucleases 
Table 1.  DNA methylation analysis methods
Pretreatment        Resolution: Global 
quantitative
Locus-specific 
PCR-based
 Genome-wide
ar ray-based NGS-based
Sodium bisulfite conversion Alu/LINE-1-PCR-
pyrosequencing
Alu/LINE-1-HRM
MSP-PCR
MethyLight
SMART-MSP
MS-HRM
Pyrosequencing
MassARRAY
Infinum
Golden Gate
RRBS
WGSBS
oxBS-Seq
Enzyme restriction digestion HPLC
LC-MS
LUMA
HpaII-PCR
MS-MLPA
MS-FLAG
DMH
MCAM
HELP
CHARM
MMASS
Methyl-Seq
MCA-Seq
MSCC
HELP-Seq
Affinity enrichment 5-mC ELISA
5-mHC ELISA
MeDIP-PCR
MIRA
MeDIP-chip
MIRA-chip
MeDIP-Seq
MethylCap-Seq
MIRA-Seq
 HPLC = High-performance liquid chromatography; LC-MS = liquid chromatography-mass spectroscopy;
LUMA = luminometric methylation assay; SMART-MSP = sensitive melting analysis after real-time methylation-
specific PCR; MS-HRM = methylation-specific high-resolution melting analysis; CHARM = comprehensive high-
throughput arrays for relative methylation; MMASS = microarray-based methylation assessment of single samples; 
–seq = followed by sequencing; WGSBS = whole-genome shotgun bisulfite sequencing; MSCC = methylation-
sensitive cut counting; MethylCap = methyl-DNA binding domain capture technique.
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(HpaII, MspI and HhaI) and their corresponding isoenzymes (not sensitive to methylation) to 
distinguish methylated from unmethylated cytosines  [18] . An important limitation is that all 
restriction enzyme-based techniques condition analysis methylation within recognition sites. 
Lastly, affinity enrichment treatment is the most recent and simplest way to enrich meth-
ylated DNA, which was first proved with the methyl-binding protein MECP2  [19] . Enrichment-
based methods are based on immunoprecipitation of genomic DNA with specific antibodies 
for methylated cytosine. An important point regarding affinity-based techniques is that they 
measure the density of methylation in a specific region. Therefore, a methylated stretch of 
DNA where methylation CG target sites are sparse might be difficult to differentiate from an 
unmethylated region. Specifically, in mammalian genomes, CG density is generally low and 
CG-dense sequences are typically unmethylated  [20] .
 The different combination of pretreatment methods and subsequent molecular biology 
techniques, such as DNA microarrays and high-throughput sequencing, generates a plethora 
of techniques for mapping DNA methylation in a feasible way on a genome-wide scale.
 Global Quantification of DNA Methylation 
 In mammalian cells, DNA methylation is found at 70–80% of CpG dinucleotides. More 
recently, global DNA methylation has been examined in surrogate tissues such as leukocyte 
DNA. A lower level of leukocyte DNA methylation has been associated with an increased risk 
of several types of cancer  [21, 22] . The processes underlying tumor behavior in long inter-
spersed nucleotide element-1 (LINE-1) hypomethylation are currently unknown. Possible 
mechanisms include activation of retroviruses at transposons, which may cause genomic 
instability, in particular chromosomal instability  [23] . This finding suggests that DNA meth-
ylation may serve as a surrogate biomarker for systemic genomic methylation and provide 
an independent risk factor for cancer development. In addition, there is widespread interest 
in finding correlations between the genomic 5-mC levels and diet, lifestyle and clinical 
disorders. In nutritional studies, it would be important to quantify global patterns of DNA 
methylation in order to evaluate the effect of nutrient intake, and a specific phenotype such 
as a different dietary pattern (i.e. diet characterized by high intake of vegetables and fruits) 
may protect against global DNA hypomethylation  [24] .
 Several methods can be used to detect the total 5-mC content in the genome. DNA can be 
digested into single nucleotides and total genomic 5-mC can be quantitated by high-perfor-
mance liquid chromatography, thin-layer chromatography, or liquid chromatography/mass 
spectroscopy, but these methods are very laborious techniques. To bypass these problems, 
several PCR-based methods [high-resolution melt (HRM) curve analysis technology or real-
time PCR or advanced pyrosequencing-based technology] have been developed to estimate 
global DNA methylation by assessing repetitive DNA elements such as Alu elements and 
LINE-1  [25, 26] . Interestingly, it has been shown that a wide range of bioactive food compo-
nents, such as folate, riboflavin, pyridoxine or methionine, regulate global DNA hypomethyl-
ation by modifying the levels of S-adenosyl-L-methionine, a methyl group donor, and 
S-adenosyl-L-homocysteine, which is an inhibitor of enzymes catalyzing the DNA methylation 
reaction  [27] . In a recent report, Schernhammer et al.  [28] showed that folate supplemen-
tation decreases the risk to develop LINE-1-hypomethylated colon cancers. In the present 
study, researchers analyzed 606 colon cancers reported in two huge cohorts (the Nurses’ 
Health Study with 121,701 women and the Health Professionals Follow-Up Study with 51,529 
men) for LINE-1 methylation level, a good indicator of cellular 5-mC level using pyrose-
quencing technology. The average of the relative amounts of C in the four CpG sites was used 
as overall LINE-1 methylation level in a given sample.
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 In parallel, simple methods have been developed for rapid detection and quantitation of 
global 5-mC, such as a competitive enzyme immunoassay in urine, isolated cells or tissue DNA 
samples  [29] .
 Locus-Specific Quantification of Methylation 
 As global methylation analyses provide no information on the genomic positions at which 
nucleotide methylation is altered, other high-resolution approaches are needed to relate such 
changes to functional outcomes. Site-specific DNA methylation levels normally tend to be 
lower than global methylation levels. It is currently estimated that 50–60% of genes have CpG 
islands  [30] , defined as a GC-rich region (GC content >50%) greater than 200 bp in length and 
having an observed CpG/expected CpG ratio of greater than or equal to 0.6  [31] . Furthermore, 
a majority of studies have focused on the methylation of CpG islands in gene promoters in 
order to correlate its levels with transcriptional expression.
 Most gene-specific methylation analysis methods are primarily ‘PCR-based’. Specifically 
primers are designed to amplify both methylated and unmethylated regions with equal effi-
ciency, as the methylation level is analyzed by different approaches. In this section, we focused 
on key quantitative techniques that determine the levels of 5-mC in a particular region of the 
genome.
 Methylation-Specific PCR  
 This method entails initial modification of DNA by sodium bisulfite treatment and subse-
quent amplification with specific primers for methylated versus unmethylated DNA. Methyl-
ation-specific PCR (MSP) requires only small quantities of DNA and it is sensitive to 0.1% 
methylated region of a given CpG island locus  [32] . Regarding nutritional studies using this 
methodology, Cordero et al.  [33]  reported that leptin and TNF-alpha promoter methylation 
levels in adipose tissue biopsies from obese women could predict the response to a low-
calorie diet.
 One significant improvement of this assay is the quantitative real-time PCR method that 
is capable of quantitating DNA methylation by using DNA oligonucleotides that anneal differ-
entially to bisulfite-converted DNA according to the methylation status. Moreover, the fluo-
rescence-based technique called MethyLight, uses three oligonucleotide primers/probes 
(forward and reverse primers, and interpositioned probe) allowing for a high degree of spec-
ificity, sensitivity, and flexibility in methylation detection  [34] . This method can be performed 
on DNA extracted from paraffin-embedded tissue (FFPE)  [35] .
 Another modification of this assay is methylation-specific fluorescent amplicon gener-
ation (MS-FLAG)  [36] . Furthermore, FLAG (fluorescent amplicon generation) is a homoge-
neous signal generation technology based on the exceptionally thermostable endonuclease 
PspGI. FLAG provides real-time signal generation during PCR by PspGI-mediated cleavage of 
quenched fluorophores at the 5 ′ -end of double-stranded PCR products. The MS-FLAG method 
uses 5 ′ -end methylation-sensitive primers added to a restriction endonuclease recognition 
sequence and, as more recognition sequences are generated, the stronger is the fluorescence 
intensity that is observed. If the primer target sequence is unmethylated, the primer will not 
be able to bind, which results in the absence of a detectable signal.
 Methylation-Sensitive HRM Analysis 
 A further method to differentiate methylated from unmethylated bisulfite-treated DNA 
is methylation-sensitive HRM (MS-HRM), a quantitative real-time PCR-based technique 
initially designed to distinguish genetic polymorphisms  [37] . The PCR products are analyzed 
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directly by dissociation curve analysis and the resulting release of an intercalating fluo-
rescent dye during melting. The degree of methylation, as represented by the C-to-T content 
in the PCR product, determines the rapidity of melting and consequent release of the dye. 
This method allows direct quantitation in a single-well assay and is particularly useful for 
assessing methylation in short fragments of DNA (a range of 150 bp) derived from FFPE 
biopsies, which are often moderately to highly degraded and have very small amounts of 
tissue. MS-HRM also provides accurate distinction between mixtures of methylated and 
unmethylated DNAs, allowing discrimination between DNA from 0 to 100% methylated as 
long as the bisulfite conversion is completely homogeneous. However, heterogeneous 
methylation across the CpG sites could influence the melting profile of the PCR product and, 
therefore, the estimates of methylation obtained by this technique  [38] . An interesting 
example of the use of MS-HRM and the genotype-epigenotype interaction was reported by 
Carroll and Parle-McDermott  [39] , who assessed whether DNA methylation in the proximal 
promoter of RUNX1, a transcription factor identified as a responder to changes in the folate/
riboﬂavin status, correlated with the MTHFR 677C>T genotype. In that study, the 
MTHFR677-TT genotype group tended to exhibit 0% DNA methylation of their proximal 
RUNX1 promoter compared to CC or CT individuals, particularly in the context of nutri-
tional status, which is in line with previous studies showing low levels of folate in TT indi-
viduals  [39, 40] .
 Pyrosequencing
Pyrosequencing is a high-throughput quantitative method used for bisulfite sequencing. 
Similar to MSP and MS-HRM, pyrosequencing requires the use of bisulfite-converted DNA and 
has the same limitations derived from this treatment. Although MS-HRM is a simpler and rela-
tively inexpensive approach for the quantification of methylation of specific CpG sites than 
pyrosequencing, this method is the gold standard technique for DNA methylation detection, 
providing also information on the methylation status of single-CpG sites. Using PCR, the DNA 
is amplified and tagged by a primer that is biotinylated. The pyrosequencing technology is 
based on the release of pyrophosphate when nucleotides incorporate into the sequencing 
primer only if it is complementary to the template DNA sequence. It is a method widely used 
in disease research and it has also been employed in different nutritional studies  [41–44] . As 
an example, a recent study describes the consequences of maternal undernutrition during 
gestation and lactation on DNA methylation and expression of the leptin gene, an adipokine 
that is involved in the regulation of body weight and food intake  [45] . The leptin promoter 
methylation differences in mice fed a low-protein diet compared with controls caused a lower 
body weight/adiposity and exhibit a higher food intake.
 Mass Spectrometry Methylation Assays (MassARRAY Assay) 
 The MassARRAY assay provides a highly sensitive method of detection based on the 
difference in fragment size that has been cleaved according to the methylation status of 
multiple CpG sites. This strategy has the ability to sequence reads up to 600 bp, which is 
considerably longer than other methods  [46] , but it also requires the use of bisulfite-convert-
ed DNA, and primers designed in regions without CpG nucleotides. Selected DNA regions are 
amplified by PCR with tagged primers, in vitro transcribed into RNA, and base-specifically 
cleaved by an endoribonuclease. Mass spectra of cleavage products are obtained by 
MassARRAY analyses based on MALDI-TOF mass spectrometry. Fragments differ in mass 
depending on the sequence changes introduced by the initial bisulfite treatment. This assay 
is used for validations of whole epigenome screening experiments (e.g. arrays or NGS tech-
nology) and candidate gene promoter analyses, and is even suitable for analyses of DNA 
extracted from FFPE tissues. Studies have shown variable site specificity of the assay, demon-
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strating ranging values between 75 to 95% concordance when validated with other sequenc-
ing methods  [47, 48] . The MassARRAY assay has been used in nutritional studies because of 
its capacity to study large fragments of DNA  [49–51] . Milagro et al.  [49]  describe how hypo-
caloric diet-induced weight loss in humans could alter the DNA methylation status of specific 
gene promoters (ATP10A, CD44 and WT1). Moreover, baseline DNA methylation patterns 
may be used as epigenetic markers that could help to predict weight loss.
 Methylation-Specific Multiplex Ligation-Dependent Probe Amplification  
 Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) is a 
semi-quantitative method for DNA methylation analysis. It is a variant of the MLPA tech-
nique, in which copy number detection is combined with the use of a methylation-sensitive 
restriction enzyme  [52] . The MS-MLPA protocol is very similar to the standard MLPA method, 
except that each MS-MLPA reaction generates two samples: one undigested sample for copy 
number detection and one digested sample for methylation detection, and MS-MLPA probes 
for target sequence contain the restriction site of the methylation-sensitive endonuclease 
HhaI. This technique has been widely used for the detection of epigenetic alterations in 
imprinting diseases, such as the Prader-Willi, Angelman and Beckwith-Wiedemann, and RSS 
syndrome  [53–55] . Furthermore, MS-MLPA is an excellent choice for quantitative analysis 
of methylation in archival FFPE samples. Both the quality and quantity of DNA may limit 
subsequent analyses, insomuch as it does not require a large amount of input, no bisulfite 
conversion is needed, and it has the ability to quantify multiple CpGs per sample at the same 
time. Pavicic et al.  [56]  determined the methylation level at 11 microRNAs (miRNA) loci 
associated with CpG islands by MS-MLPA assays in order to correlate with hypermethylation 
at classic tumor suppressor promoters in normal and tumor tissues from FFPE biopsies. 
MS-MLPA assay has not yet been performed in the nutrition field. Nonetheless, this tech-
nique would enable the development of nutritional custom panels of middle throughput 
quantifying the methylation level of different loci such as miRNA genes that could be epige-
netically regulated through the associated CpG islands and some could additionally modulate 
the epigenome by putatively targeting the DNA methyltransferases, suggesting an epigenetic 
regulation of their expression.
 Methylated DNA Affinity Enrichment Assay 
 In affinity-based approaches, such as the methylated DNA immunoprecipitation (MeDIP) 
 [20] and the methylated CpG island recovery assay (MIRA)  [57] , fragmented DNA is immuno-
precipitated using a monoclonal antibody to 5-mC or by methylated DNA-binding proteins 
(MBD2b/MBD3L1 complex). The resulting enrichment of methylated DNA in the immuno-
precipitated fraction can be determined by PCR-based methods to assess the methylation 
state of specific regions. Alternatively, MeDIP can be combined with large-scale analyses 
using microarrays as a genome-wide experimental readout, as described below.
 In addition, some technical improvements have allowed the quantification of methylated 
DNA from low amounts of cells or even to distinguish between 5-mC and 5-hmC by specific 
antibodies  [58, 59] .
 An interesting example of the use of MeDIP followed by quantitative PCR was reported 
by Barres et al.  [60] . With this method, they found that acute exercise induced a dose-
dependent expression of PGC-1α, PDK4, and PPAR-δ in human soleus muscle, together with 
a marked hypomethylation in their promoters. Similarly, the same promoter had a markedly 
decreased methylation level in mouse soleus muscles 45 min after ex vivo contraction. In L6 
myotubes, caffeine exposure enhanced an intramembranous charge movement in skeletal 
muscle by increasing cytoplasmic Ca2+ concentrations  [61] , and induced gene hypomethyl-
ation of PGC-1α, PDK4, and PPAR-δ in parallel with an increase in the respective mRNA 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
id
ad
 d
e 
Na
va
rra
   
   
   
   
   
   
   
   
   
   
   
15
9.
23
7.
12
.6
5 
- 9
/2
3/
20
13
 1
0:
47
:0
6 
AM
90J Nutrigenet Nutrigenomics 2013;6:83–96
 DOI: 10.1159/000350749 
 Mansego et al.: Techniques of DNA Methylation Analysis with Nutritional Applications 
www.karger.com/jnn
© 2013 S. Karger AG, Basel
content, and this effect was blocked by dantrolene, an inhibitor of Ca2+ release. Collectively, 
their results provide evidence that acute exercise induces gene-speciﬁc DNA hypomethyl-
ation in human skeletal muscle mediated by caffeine  [60] . 
 Genome-Wide DNA Methylation Analysis 
 Similarly to the revolution that took place in transcriptomic studies with the development 
of gene expression microarrays, rapidly improving technologies are increasing the capacity 
to assess either locus-specific (epigenetic) or genome-wide DNA methylation (epigenomics). 
 The different principles used to analyze locus-specific DNA methylation patterns are 
nowadays combined with microarrays or NGS  [62, 63] . However, microarrays are being grad-
ually replaced by sequencing-based approaches, which hold the promise of providing 
biological insights and new avenues for translational research and clinical applications.
 Microarray-Based Methylation Analysis 
 Three main classes of microarray-based methods have been developed to quantify 5-mC 
distribution in genomes: (1) those based on sodium bisulfite modification; (2) those utilizing 
methylation-sensitive restriction enzymes, and (3) those enriching for highly methylated 
regions using an antibody specific for 5-mC or methyl-binding proteins.
 In bisulfite-based epigenotyping, the microarrays are designed using pairs of oligonucle-
otide hybridization probes targeting the CpG sites of interest. One probe is complementary to 
the unaltered methylated sequence, and the other is complementary to the unmethylated 
sequence. The Illumina Methylation Assay (Infinium or Golden Gate technologies) is one of 
the methods that apply the bisulfite sequencing technology on a microarray level to generate 
genome-wide methylation data, as it is able at once to identify more than 485,000 methyl-
ation sites per sample at single-nucleotide resolution.
 An increasing number of reports are found using these technologies in the nutrition field. 
Recently, Jacobsen et al.  [64] examined the methylation status of 27,578 CpG sites from 
14,475 genes in skeletal muscle biopsies from 21 healthy young men after the ingestion of a 
short-term high-fat overfeeding (HFO) diet and a control diet. They used a bead array-based 
methylation assay, and described that a HFO diet introduced widespread DNA methylation 
changes affecting 6,508 genes (45%), with a maximum methylation change of 13%. The HFO-
induced methylation changes were only partially and nonsignificantly reversed after 6–8 
weeks. Milagro et al.  [49]  used a combination of a high-throughput microarray-based assay 
with a second more specific technique (MassARRAY assay), including more individuals than 
in the first technique, which allowed to find new putative biomarkers and to reliably validate 
them. With this dual approach, it has been proven that hypocaloric diets induce changes in 
the DNA methylation pattern in 25 overweight and obese men under a caloric restriction 
intervention. Moreover, a baseline DNA methylation profile may be used as an early indicator 
of response to the metabolic effects of the weight loss program  [49, 65] . Alterations in the 
DNA methylation levels primarily affect genes involved in inflammation, the reproductive 
system and cancer.
 One of the enzyme-based methods coupled to array-based analysis is methylated CpG 
island amplification with microarray hybridization (MCAM), which uses the differential 
methylation sensitivities and cutting behaviors of two endonucleases (SmaI and XmaI) with 
a final array hybridization step  [66] . An alternative approach is differential methylation 
hybridization (DMH), which involves digestion of one pool of DNA with a methylation-
sensitive restriction enzyme and a mock digestion of another pool. This process produces 
parallel DNA pools that are amplified and labeled with different fluorescent dyes for two-
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
id
ad
 d
e 
Na
va
rra
   
   
   
   
   
   
   
   
   
   
   
15
9.
23
7.
12
.6
5 
- 9
/2
3/
20
13
 1
0:
47
:0
6 
AM
91J Nutrigenet Nutrigenomics 2013;6:83–96
 DOI: 10.1159/000350749 
 Mansego et al.: Techniques of DNA Methylation Analysis with Nutritional Applications 
www.karger.com/jnn
© 2013 S. Karger AG, Basel
color array hybridization  [67] . The relative fluorescent signal intensities can be used to 
extract DNA methylation information at the corresponding loci on the array. An adaptation 
of DMH, known as MethylScope, utilizes the endonuclease McrBC to randomly cut sheared 
DNA  [68]  [instead of DNA digested with MseI restriction enzymes whose recognition sequence 
(TTAA) is found frequently within bulk DNA, but is rarely found within CpG islands which 
remain intact after digestion  [19] ]. The combination with the tiling array (a subtype of micro-
array that functions by hybridizing labeled DNA or RNA target molecules to probes fixed onto 
a solid surface) design and data processing is referred to as comprehensive high-throughput 
arrays for relative methylation  [69] . A further variation of DMH, combined with array, is the 
method called microarray-based methylation assessment of single samples, which uses a 
cocktail of methylation-sensitive restriction enzymes to digest one pool of DNA and McrBC to 
digest the other pool  [70] . Another method, known as HpaII tiny fragment enrichment by 
ligation-mediated PCR (HELP), uses ligation-mediated PCR for the amplification of HpaII or 
MspI genomic restriction fragments followed by array hybridization  [71] .
 Finally, another affinity enrichment-based method involves the coupling of MeDIP with 
DNA microarrays to obtain relative methylation levels at the loci represented on the array. 
Defining a region as methylated from the MeDIP-chip data depends on several factors, 
including the sequence context of the loci (CpG-rich versus CpG-poor regions), the number of 
probes in a region, and their hybridization values. DNA methylation status is expressed 
relative to the input DNA or to another sample. This MeDIP-chip has been widely used in the 
analysis of cancer cell lines  [20, 72] and stem cells  [73, 74] , among others. An interesting 
approach was used by Bell et al.  [75] in the analysis of genotype-epigenotype interactions in 
the context of type 2 diabetes, finding an increased DNA methylation on the FTO obesity 
susceptibility haplotype by using methylated DNA immunoprecipitation on a targeted array 
(MeDIP-chip).
 However, methylation changes identified by microarray experiments will continue to 
require validation by one or more of the locus-specific methods  [76] . Moreover, the relative 
finesse of DNA methylation changes induced by nutritional exposures will motivate continued 
development of analytical methods that should be rapid, inexpensive, highly sensitive and 
quantitatively accurate. On the contrary, although methylation microarrays are a powerful 
tool for epigenetic studies, they have an important limitation in that they analyze only a small 
part of the CpG sites of the genome. 
 NGS-Based Methylation Analysis 
 NGS has revolutionized the genomic research field since its introduction in 2007  [77] . 
More recently, this technology has been adapted to epigenomic research including DNA meth-
ylation profiling at high resolution and low cost. Several sequencing strategies are available 
and the choice of platform and methodology is dependent on the scientific application, the 
cost, and the capacity for extensive bioinformatics analysis.
 Sodium bisulfite conversion followed by massively parallel sequencing (Bisulfite-seq) 
has become an increasingly used method for performing epigenetic profiles in the human 
genome  [78] . Bisulfite-seq is well suited to the investigation of epigenetic profile from clinical 
tissue samples  [79, 80] , and can be applied to very small quantities of DNA  [81] including 
formalin-fixed samples  [82] . Comprehensive mapping of DNA methylation in relevant clinical 
cohorts is likely to identify new disease genes and potential drug targets, help to establish the 
relevance of epigenetic alterations in disease and provide a rich source of potential biomarkers 
 [83] .
 Whole-genome bisulfite sequencing provides coverage at a single-base pair resolution 
and is the most comprehensive technique, covering more than 90% of cytosines in the human 
genome  [9] . This method requires the most extensive bioinformatics tools and is the most 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
id
ad
 d
e 
Na
va
rra
   
   
   
   
   
   
   
   
   
   
   
15
9.
23
7.
12
.6
5 
- 9
/2
3/
20
13
 1
0:
47
:0
6 
AM
92J Nutrigenet Nutrigenomics 2013;6:83–96
 DOI: 10.1159/000350749 
 Mansego et al.: Techniques of DNA Methylation Analysis with Nutritional Applications 
www.karger.com/jnn
© 2013 S. Karger AG, Basel
expensive because more sequences are needed to cover the entire genome. An alternative to 
the whole-genome bisulfite sequencing is RRBS, which uses restriction fragment size selection 
to select a portion of the genome enriched for CpG islands and gene regulatory sequences  [11, 
84] . Specifically, this technology covers approximately 12% of all CpG dinucleotides and 84% 
of all CpG islands in the human genome  [84] .
 As with microarray analysis, approaches focused on affinity-based sequencing, such as 
MeDIP-seq or MethylCap [methyl-DNA binding domain (MBD) capture technique], or enzy-
matic-based sequencing technologies, like Methyl-Seq and HELP-Seq have been described 
 [85] .
 More recently, a new chemistry called oxidative bisulfite sequencing (oxBS-Seq) has 
allowed to sequence the recently discovered base 5-hmC in whole-genome studies  [86] . 
Although there are other techniques to quantify this modification such as MeDIP (array or 
sequencing) or competitive enzyme immunoassay with specific 5-hmC antibody  [29, 87] , or 
oxBS-Seq development, 5-hmC can be detected at single-base resolution. This method is 
based on the selective chemical oxidation of 5-hmC to 5-fC, which enables bisulfite conversion 
of 5-fC to uracil. It has been applied to sequence 5-hmC in embryonic stem cell genomic DNA, 
and high levels of 5-hmC were found in CpG islands associated with transcriptional regulators 
and in long interspersed nuclear elements, suggesting that these regions might undergo 
epigenetic reprogramming. Furthermore, the global balance between 5-mC and 5-hmC in the 
genome has been described as a critical step for regulating gene expression to maintain 
cellular functions  [88–90] . In this sense, the global quantification of 5-hmC is becoming crucial 
to understand dynamic epigenetic mechanisms and changes that occur in the cells. For 
example, it has been reported that the aging process is connected with changes in the 
epigenetic machinery in mouse hippocampus, and caloric restriction acts as an inductor of a 
complex interplay involving chromatin remodeling and the balance between methylation and 
hydroxymethylation  [91] .
 Despite these advances, and probably because of its high cost, the study of methylation 
changes by using these new approaches is slowly finding its way into metabolic and nutri-
tional studies. In spite of this, further studies in this area will begin to emerge in the coming 
years.
 Conclusion 
 A large number of strategies have been used to examine DNA methylation, and these 
methods have progressed from small-scale candidate gene analysis to the ability to construct 
whole-genome methylation profiles. Clearly, there is no one method of DNA methylation 
analysis that is best suited for every application. Researchers should conduct a preliminary 
analysis focused on the type of validation and information provided by each technique in 
order to select the best method fitting for their research.
 Furthermore, it has recently become apparent that, in addition to DNA methylation, there 
are other modifications of DNA, such as hydroxymethylation, that play a role in epigenetic 
regulation of gene expression. These findings suggest that DNA modifications are more 
dynamic than previously thought. In the next few years, given the speed with which NGS has 
been adopted in epigenetic research and turned into an effective tool for hypothesis testing 
and generation, important nutrient-gene interaction questions will likely ﬁnd an answer. The 
main limitations will be the following: often in research the hypotheses must be clear and as 
simple as possible, and the experimental design adequate for the purpose, avoiding 
confounding factors associated with environmental and nutritional variables. This task is 
difficult in a field in which many dietary components (fat, methyl donors, polyphenols, amino 
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acids, minerals) and metabolic processes (obesity, inflammation, oxidative stress, hypergly-
cemia, stress, endocrine imbalances, etc.) have been reported to be involved in the epigenetic 
control of gene expression, especially during the in utero and early postnatal periods  [84] .
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